Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|---|
| Total income (before exceptional items) | 1,370† | 1,008† | 701† | 621† |
| Net profit | 366 | 160 | 44 | 83 |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| CHETANKUMAR CHHAGANLAL VAGHASIA | Executive Director | June 30, 2026 |
| NARESHKUMAR RAMJIBHAI PATEL | Executive Director | June 30, 2026 |
| RAM MOHAN LOKHANDE | Executive Director | June 30, 2026 |
| VIRENDRA NATH MISHRA | Executive Director | June 30, 2026 |
| ANITA BANDYOPADHYAY | Independent Director | June 30, 2026 |
| GIRIKRISHNA MANIAR | Independent Director | June 30, 2026 |
| HETAL MADHUKANT GANDHI | Independent Director | June 30, 2026 |
| RICHA MANOJ GOYAL | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
